- Home
- MTH vs LNTH Comparison
MTH vs LNTH Comparison
Compare MTH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTH | LNTH |
|---|---|---|
| Founded | 1985 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.4B |
| IPO Year | 1988 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MTH | LNTH |
|---|---|---|
| Price | $66.09 | $66.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $82.75 | $78.00 |
| AVG Volume (30 Days) | 751.1K | ★ 1.1M |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.50 | 2.39 |
| Revenue | ★ $6,043,594,000.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $5.61 | $0.52 |
| P/E Ratio | ★ $8.86 | $28.07 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $59.27 | $47.25 |
| 52 Week High | $84.74 | $111.29 |
Technical Indicators
Market Signals| Indicator | MTH | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 64.17 |
| Support Level | $65.33 | $66.20 |
| Resistance Level | $67.33 | $67.45 |
| Average True Range (ATR) | 1.48 | 1.71 |
| MACD | -0.40 | -0.09 |
| Stochastic Oscillator | 13.93 | 72.98 |
Price Performance
Historical ComparisonAbout MTH Meritage Homes Corporation
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.